Complete HEOR Solutions (CHEORS) Revenue and Competitors

North Wales, USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Complete HEOR Solutions (CHEORS)'s estimated annual revenue is currently $23.5M per year.(i)
  • Complete HEOR Solutions (CHEORS)'s estimated revenue per employee is $201,000

Employee Data

  • Complete HEOR Solutions (CHEORS) has 117 Employees.(i)
  • Complete HEOR Solutions (CHEORS) grew their employee count by 34% last year.

Complete HEOR Solutions (CHEORS)'s People

NameTitleEmail/Phone
1
VP, Evidence GenerationReveal Email/Phone
2
VP, Economic ModelingReveal Email/Phone
3
DirectorReveal Email/Phone
4
Director Business Development & SalesReveal Email/Phone
5
Manager, Health Economics and Outcomes ResearchReveal Email/Phone
6
ManagerReveal Email/Phone
7
Associate ManagerReveal Email/Phone
8
Engagement ManagerReveal Email/Phone
9
Associate ManagerReveal Email/Phone
10
Senior HEOR Manager, ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Complete HEOR Solutions (CHEORS)?

CHEORS provides cutting-edge health economic insights emphasizing a wholistic approach towards HEOR. We provide best-in-class HEOR services including economic modeling, country adaptations of the economic models for HTA submissions, systematic literature review, meta-analysis, and database analysis. In addition, we assist pharmaceutical companies with market-access planning and offer support to payers with modifying economic models and evaluating value-based contracts.

keywords:N/A

N/A

Total Funding

117

Number of Employees

$23.5M

Revenue (est)

34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.6M1283%N/A
#2
$33.1M16711%N/A
#3
$53.3M1676%N/A
#4
$52.6M19526%N/A
#5
$75.4M254-8%N/A